Renuka Iyer, MD [clinicaltrials_resource:d649b49a5303e29e3e2b24c3225cdc96]
Gemcitabine, Capecitabine, and Bevacizumab in Treating Patients With Metastatic or Unresectable Pancreatic Cancer [clinicaltrials:NCT00100815]Paricalcitol and Gemcitabine in Treating Patients With Advanced Cancer [clinicaltrials:NCT00217477]clinicaltrials:NCT00470535Gemcitabine, Capecitabine, and Bevacizumab in Treating Patients With Pancreatic Cancer That Can Be Removed By Surgery [clinicaltrials:NCT00524069]clinicaltrials:NCT00524121clinicaltrials:NCT00524316clinicaltrials:NCT01007552
overall official [clinicaltrials_vocabulary:overall-official]
Renuka Iyer, MD [clinicaltrials_resource:d649b49a5303e29e3e2b24c3225cdc96]
Bio2RDF identifier
d649b49a5303e29e3e2b24c3225cdc96
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:d649b49a5303e29e3e2b24c3225cdc96
affiliation [clinicaltrials_vocabulary:affiliation]
last name [clinicaltrials_vocabulary:last-name]
Renuka Iyer, MD
phone [clinicaltrials_vocabulary:phone]
716-845-2300
role [clinicaltrials_vocabulary:role]
Principal Investigator
identifier
clinicaltrials_resource:d649b49a5303e29e3e2b24c3225cdc96
title
Renuka Iyer, MD
@en
type
label
Renuka Iyer, MD [clinicaltrials_resource:d649b49a5303e29e3e2b24c3225cdc96]
@en